Replies to post #10031 on The Rising Influence of Rising Affluence

[anesthesia doc]

At least the last paragraph gives hope for 2016 with the thought of a V shaped recovery.

"Core’s view for the remainder of the year continues to be constructive, yet uncertain, while the Company's customers are prioritizing operating plans for conducting their activities in this environment. Consequently, Core is not able to provide quantitative guidance for the remainder of the year at this time, although from a qualitative perspective, the Company’s sense is that industry activity levels will flatten in the third and fourth quarters of 2015, with a V-shaped recovery in activity levels starting in the first quarter of 2016."

[DewDiligence]

CLB reports 2Q15 results—these are the bullet points from the press release:

http://www.sec.gov/Archives/edgar/data/1000229/000100022915000099/exhibit99-1_pressreleaseq2.htm

• REVENUE OF $204 MILLION DECREASED 5% SEQUENTIALLY

• EPS OF $0.82, EX-ITEM, DECLINED 5% SEQUENTIALLY

• H1 2015 FREE CASH FLOW REPRESENTS 173% OF EARNINGS

• 360,000 SHARES REPURCHASED IN Q2 2015 APPROXIMATES 1% OF SHARE COUNT

• COMPANY CLOSES ON PURCHASE OF SANCHEZ TECHNOLOGIES EXTENDING LEADERSHIP IN HPHT RESERVOIR FLUID ANALYSIS

• COMPANY RAISES GUIDANCE ABOVE STREET EPS CONSENSUS FOR Q3 & Q4 2015

Emphasis added.

The stock is up about 4% in AH trading after declining about 3% during regular trading.

I’ll have more to say after the CC tomorrow morning.